Last updated on 13 Nov, 2025 | 09:15 IST
Rights Ratio | Face Value  | Premium | Ex-Right Date | Record Date  | Announcement Date |
|---|---|---|---|---|---|
| No data found | |||||
*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.
Existing shareholders of Jagsonpal Pharmaceuticals as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.
Shareholders can apply for Jagsonpal Pharmaceuticals rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.
No! Participation in Jagsonpal Pharmaceuticals rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.
No, Jagsonpal Pharmaceuticals hasn’t had any right issues as of {{current_date}} in last 2023-2025
No, Jagsonpal Pharmaceuticals hasn’t had any right issues as of {{current_date}} in last 2023-2025